Mediaboss Marketing

By Corrie Driebusch and Drew FitzGerald

Among the companies whose shares are expected to actively trade in Fridays session are Shutterfly, Zynga and Ascena Retail Group.

Eastman Kodak said it agreed the proposed sale of its Kodak Gallery online photo services business to Internet-based personal publishing service Shutterfly for $23.8 million. Shutterfly shares surged 15% to $30.90 premarket.

Zynga late Thursday said it would introduce a new platform to allow people to be able to play the companys popular titles on Zynga.com instead of relying on social networks such as Facebook. Shares of Zynga jumped 3.9% to $15.04 premarket.

Ascenas fiscal second-quarter earnings jumped 50% as the apparel retailer posted stronger same-store sales, led by its Justice brand. Shares jumped 8.5% to $42.25 premarket after the company easily beat earnings and revenue expectations.

Flow Internationals fiscal third-quarter profit more than doubled as the maker of water-jet machines saw continued strength in its standard segment, though its advanced segment continued to post lower sales. Shares jumped 8.1% premarket to $4.28.

Foot Lockers fiscal fourth-quarter earnings rose 42% as innovative apparel and footwear merchandise led to stronger consumer demand, helping the retail chain report higher same-store sales and expanding margins. The companys fourth-quarter results easily topped Wall Streets expectations, though Foot Lockers stock fell 1.3% to $29.13 premarket as there may have been expectations same-store sales would have risen even higher than the 7.5%-increase reported.

SciClone Pharmaceuticals said it will discontinue the development of a drug to treat oral mucositis after a study did not yield positive results. The pharmaceutical companys shares dropped 8.2% to $4.15 premarket.

A123 Systems reported preliminary 2011 revenue that missed the battery developers November estimates amid a series of fourth-quarter charges. Shares fell 5.3% to $1.80 premarket.

Columbia Laboratories plans to reduce its work force by 10 employees to 14 after the U.S. Food and Drug Administration on Monday rejected a co-developed product intended for pregnant women. Shares jumped 12% to 75 cents premarket.

Read more:
Stocks to Watch: Shutterfly, Zynga, Ascena Retail Group and More